Volume 23, Number 4—April 2017
Dispatch
Assessing Sensitivity and Specificity of Surveillance Case Definitions for Zika Virus Disease
Table 2
Case definition | Sensitivity, % | Specificity, % | PPV, % | NPV, % | LR+ (95% CI) | LR– (95% CI) |
---|---|---|---|---|---|---|
United States | 100 | 2 | 42 | 100 | 1.02 (1.00–1.04) | 0 |
WHO | 38 | 70 | 47 | 61 | 1.3 (0.9–1.7) | 0.9 (0.8–1.0) |
PAHO | 49 | 76 | 59 | 68 | 2.1 (1.5–2.8) | 0.7 (0.6–0.8) |
ECDC | 56 | 74 | 60 | 70 | 2.1 (1.6–2.8) | 0.6 (0.5–0.7) |
Singapore MOH | 54 | 76 | 61 | 70 | 2.2 (1.7–3.0) | 0.6 (0.5–0.7) |
*ECDC, European Centre for Disease Prevention and Control; LR, likelihood ratio; MOH, Ministry of Health; NPV, negative predictive value; PAHO, Pan American Health Organization; PPV, positive predictive value; WHO, World Health Organization; +, positive; –, negative.
Page created: March 17, 2017
Page updated: March 17, 2017
Page reviewed: March 17, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.